Lv1
23 积分 2020-09-14 加入
Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants
8小时前
已完结
Structural insights into binding of therapeutic channel blockers in NMDA receptors
8小时前
已完结
5-HT2A Receptors: Pharmacology and Functional Selectivity
2天前
求助中
Structure-based discovery of nonhallucinogenic psychedelic analogs
2天前
已完结
Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression
8天前
已完结
Elucidating Binding Selectivity in Cyclin-Dependent Kinases (CDKs) 4, 6, and 9: Development of Highly Potent and Selective CDK4/9 Inhibitors
29天前
已完结
The novel lysophosphatidic acid receptor 1-selective antagonist, ACT-1016-0707, has unique binding properties that translate into effective anti-fibrotic and anti-inflammatory activity in different models of pulmonary fibrosis
1个月前
已完结
Critical Non-Covalent Binding Intermediate for an Allosteric Covalent Inhibitor of SUMO E1
1个月前
已完结
Harnessing Medicinal Chemical Intuition from Collective Intelligence
1个月前
已完结
Hotspot Identification and Drug Design of Protein–Protein Interaction Modulators Using the Fragment Molecular Orbital Method
1个月前
已完结
皖公网安备34019202002308
